Posted On: 05/10/2016 7:19:40 AM
Post# of 23091
MOUNTAIN VIEW, Calif. and BARCELONA, Spain, May 10, 2016 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA, "Alexza"
and Grupo Ferrer Internacional, S.A. ("Ferrer" today announced that they have entered into a definitive agreement under which Ferrer Pharma Inc. ("Ferrer Pharma" , a wholly-owned subsidiary of Ferrer, will acquire Alexza for $0.90 per share in cash. In addition to the upfront cash payment, Alexza stockholders will be granted contingent value rights to receive cash payments in four payment categories if specified milestones are achieved following the closing. The transaction is expected to close in the second quarter of 2016 and is subject to customary closing conditions. https://finance.yahoo.com/news/alexza-pharmac...00482.html
and Grupo Ferrer Internacional, S.A. ("Ferrer" today announced that they have entered into a definitive agreement under which Ferrer Pharma Inc. ("Ferrer Pharma" , a wholly-owned subsidiary of Ferrer, will acquire Alexza for $0.90 per share in cash. In addition to the upfront cash payment, Alexza stockholders will be granted contingent value rights to receive cash payments in four payment categories if specified milestones are achieved following the closing. The transaction is expected to close in the second quarter of 2016 and is subject to customary closing conditions. https://finance.yahoo.com/news/alexza-pharmac...00482.html
(1)
(0)
Here We Go!!!!
